Serum markers modestly improve fecal SDC2 detection of colorectal cancer
A retrospective hospital-based study found that combining fecal SDC2 methylation with serum tumor markers modestly improved colorectal cancer discrimination, with ...
A retrospective hospital-based study found that combining fecal SDC2 methylation with serum tumor markers modestly improved colorectal cancer discrimination, with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.